Akelos, Inc.

SEC filing

Biotechnology · New York, NY

Form D on EDGAR

Amount raised$1.5Msold at filing

Total offeringNot stated

Investors in the raise81count reported to the SEC

FiledMar 16, 2026first sale Mar 9, 2026

Form D does not name the investors. If a news report names them, they appear here.

Named in the filing

Steven FoxExecutive Officer

Executive officers, directors and promoters as listed on the Form D.